De-Escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study.
COVID-19
mathematical model
pandemics
physical and social distancing relaxation
reopening
Journal
Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988
Informations de publication
Date de publication:
16 May 2020
16 May 2020
Historique:
received:
01
05
2020
revised:
14
05
2020
accepted:
14
05
2020
entrez:
21
5
2020
pubmed:
21
5
2020
medline:
21
5
2020
Statut:
epublish
Résumé
Since the beginning of the COVID-19 pandemic, most Canadian provinces have gone through four distinct phases of social distancing and enhanced testing. A transmission dynamics model fitted to the cumulative case time series data permits us to estimate the effectiveness of interventions implemented in terms of the contact rate, probability of transmission per contact, proportion of isolated contacts, and detection rate. This allows us to calculate the control reproduction number during different phases (which gradually decreased to less than one). From this, we derive the necessary conditions in terms of enhanced social distancing, personal protection, contact tracing, quarantine/isolation strength at each escalation phase for the disease control to avoid a rebound. From this, we quantify the conditions needed to prevent epidemic rebound during de-escalation by simply reversing the escalation process.
Identifiants
pubmed: 32429450
pii: biology9050100
doi: 10.3390/biology9050100
pmc: PMC7284446
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Public Health. 2020 May;5(5):e261-e270
pubmed: 32220655
J Clin Virol. 2020 Jun;127:104371
pubmed: 32315817
Int J Infect Dis. 2020 Jun;95:288-293
pubmed: 32171948
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):139-144
pubmed: 32057211
PLoS Comput Biol. 2012;8(9):e1002673
pubmed: 23028275
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244365
Ear Nose Throat J. 2020 Apr 13;:145561320920762
pubmed: 32283980
J Clin Med. 2020 Feb 07;9(2):
pubmed: 32046137